Skip to main content
  • Subscribe
  • Register
  • Sign in
  • Membership
  • Events
  • Knowledge Center
  • About
  • Subscribe
  • Register
  • Sign in
taub.png
Stephen Taub
Premium
Life Sciences Funds Show Some Signs of Health
Many funds have erased a big slice of their early-year losses but still have a long way to go to break even.
Stephen Taub September 15, 2022
 Asim Hafeez/Bloomberg

Asim Hafeez/Bloomberg

Life sciences and biopharma hedge funds are on a three-month winning streak.A number of funds posted another round of strong gains in August, a month in which the broad market averages were down sharply. This has boosted hope that the devastating multiyear selloff among fledgling

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.


Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

LinkedIn
X
Bluesky

4.12.03 build:2025-12-12   Login